CMCT on Nasdaq
CIM Commercial Trust Corporation
Real estate investment fund.1
Price unavailable
Last updated Oct 16, 2026.
Overview
Compare with American Assets Trust, Inc., SELECTIS HEALTH, INC. or Strategic Student & Senior Housing Trust, Inc., or pick any stock.
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
What sells
Revenue by product, business segment and region, as the company reports it to the SEC.
Business segments
Office Properties brought in 44% of the revenue CIM Commercial Trust Corporation broke down this way in fiscal 2025.
Business segments by year
| Business segments | 2024 | 2025 |
|---|---|---|
| Office Properties | $54.3M | $50.1M |
| Hotel Properties | $37.7M | $39.6M |
| Multifamily Properties | $19.5M | $15.8M |
| Lending Division | $10.8M | $9.0M |
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Interest99¢$40.2M
- Income tax1¢$497.0K
Out of $39.6M in revenue.4 The company lost money this year.
Where each dollar of operating cash went, fiscal 2025
- Kept or used elsewhere100¢$5.8M
Out of $5.8M of cash from operations.4
Financial statements
Every line of the income statement in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Rental and other property income | $65.4M | $72.3M |
| Hotel income | $39.6M | $37.7M |
| Interest and other income | $11.6M | $14.6M |
| Total Revenues | $116.7M | $124.5M |
| Rental and other property operating | $67.0M | $68.0M |
| Asset management and other fees to related parties | $1.4M | $1.8M |
| Interest | $40.2M | $36.9M |
| General and administrative | $5.4M | $7.0M |
| Transaction-related costs | $1.5M | $1.4M |
| Depreciation and amortization | $27.1M | $27.4M |
| Loss on early extinguishment of debt (Note 7) | $88.0K | $1.4M |
| Impairment of real estate (Note 3) | $3.7M | $0 |
| Loss on assets held for sale (Note 5) | $298.0K | $0 |
| Total Expenses | $152.7M | $148.7M |
| Loss from unconsolidated entities | -$3.8M | -$806.0K |
| Gain on sale of real estate (Note 3) | $679.0K | $0 |
| LOSS BEFORE PROVISION FOR INCOME TAXES | -$39.1M | -$25.0M |
| Provision for income taxes | $497.0K | $798.0K |
| NET LOSS | -$39.6M | -$25.8M |
| Net loss attributable to noncontrolling interests | $573.0K | $575.0K |
| NET LOSS ATTRIBUTABLE TO THE COMPANY | -$39.0M | -$25.2M |
| Redeemable preferred stock dividends declared or accumulated (Note 11) | -$21.2M | -$29.7M |
| Redeemable preferred stock deemed dividends (Note 11) | $0 | -$755.0K |
| Redeemable preferred stock redemptions (Note 11) | -$1.4M | -$17.7M |
| NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS | -$61.6M | -$73.3M |
| Basic (in usd per share) | -$67.08 | -$431.43 |
| Diluted (in usd per share) | -$67.08 | -$431.43 |
| Basic (in shares) | 919.0K shares | 170.0K shares |
| Diluted (in shares) | 919.0K shares | 170.0K shares |
Every line of the balance sheet in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 |
|---|---|---|---|
| Investments in real estate, net | $698.1M | $709.2M | |
| Investments in unconsolidated entities | $31.1M | $33.7M | |
| Cash and cash equivalents | $15.4M | $20.3M | |
| Restricted cash | $22.2M | $32.6M | |
| Loans receivable, net (Note 5) | $0 | $56.2M | |
| Accounts receivable, net | $2.6M | $4.3M | |
| Deferred rent receivable and charges, net | $18.7M | $19.9M | |
| Other intangible assets, net | $439.0K | $3.6M | |
| Other assets | $4.7M | $9.8M | |
| Assets held for sale, net (Note 5) | $65.9M | $0 | |
| TOTAL ASSETS | $859.2M | $889.6M | |
| Debt, net | $509.8M | $505.7M | |
| Accounts payable and accrued expenses | $27.0M | $32.2M | |
| Due to related parties | $22.8M | $14.1M | |
| Other liabilities | $11.4M | $10.5M | |
| Liabilities associated with assets held for sale, net (Note 5) | $22.0M | $0 | |
| Total liabilities | $592.9M | $562.5M | |
| REDEEMABLE PREFERRED STOCK: Series A1 cumulative redeemable preferred stock, $0.001 par value; 24,508,664 and 25,045,401 shares authorized as of December 31, 2025 and December 31, 2024, respectively; no shares issued and outstanding as of December 31, 2025, respectively and 913,630 and 913,590 shares issued and outstanding as of December 31, 2024; liquidation preference of $25.00 per share, subject to adjustment | $0 | $20.8M | |
| Common stock, $0.001 par value; 900,000,000 shares authorized; 2,699,686 shares issued and outstanding as of December 31, 2025 and 466,180 shares issued and outstanding as of December 31, 2024 | $3.0K | $119.0K | |
| Additional paid-in capital | $1.0B | $995.0M | |
| Distributions in excess of earnings | -$1.1B | -$1.0B | |
| Total stockholders equity | $265.4M | $304.5M | |
| Noncontrolling interests | $888.0K | $1.7M | |
| Total equity | $266.2M | $306.3M | $376.8M |
| TOTAL LIABILITIES, REDEEMABLE PREFERRED STOCK, AND EQUITY | $859.2M | $889.6M | |
| Temporary equity, par value (in usd per share) | $0.00 | $0.00 | |
| Temporary equity, shares authorized (in shares) | 24.5M shares | 25.0M shares | |
| Temporary equity, shares issued (in shares) | 0 shares | 913.6K shares | |
| Temporary equity, shares outstanding (in shares) | 0 shares | 913.6K shares | |
| Temporary equity, liquidation preference per share (in usd per share) | $25.00 | $25.00 | |
| Common stock, par value (in usd per share) | $0.00 | $0.00 | |
| Common stock, authorized shares (in shares) | 900.0M shares | 900.0M shares | |
| Common stock, issued shares (in shares) | 2.7M shares | 466.2K shares | |
| Common stock, outstanding shares (in shares) | 2.7M shares | 466.2K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow in the latest annual report, as filed.4
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$39.6M | -$25.8M |
| Depreciation and amortization, net | $27.2M | $27.7M |
| Loss (gain) on interest rate caps | $149.0K | -$463.0K |
| Gain on sale of real estate | -$679.0K | $0 |
| Impairment of real estate | $3.7M | $0 |
| Loss on early extinguishment of debt | $88.0K | $1.4M |
| Loss on assets held for sale | $298.0K | $0 |
| Amortization of deferred debt origination costs | $2.8M | $2.1M |
| Amortization of premiums and discounts on debt | $103.0K | $24.0K |
| Unrealized premium adjustment | $557.0K | $1.0M |
| Amortization of deferred costs and accretion of fees on loans receivable, net | -$344.0K | -$249.0K |
| (Recoveries) write-offs of uncollectible receivables | -$1.5M | $1.3M |
| Write-off of other deferred costs | $0 | $491.0K |
| Deferred income taxes | -$137.0K | -$36.0K |
| Stock-based compensation | $220.0K | $220.0K |
| Loss from unconsolidated entities | $3.8M | $806.0K |
| Loans funded, held for sale to secondary market | -$18.7M | -$30.2M |
| Proceeds from sale of guaranteed loans | $19.1M | $28.8M |
| Principal collected on loans subject to secured borrowings | $51.0K | $1.6M |
| Commitment fees remitted and other operating activity | -$421.0K | -$806.0K |
| Accounts receivable | $597.0K | $91.0K |
| Other assets | $2.6M | $4.7M |
| Accounts payable and accrued expenses | $1.5M | -$2.0M |
| Deferred leasing costs | -$2.8M | -$1.8M |
| Other liabilities | -$1.6M | -$2.5M |
| Due to related parties | $8.8M | $10.6M |
| Net cash provided by operating activities | $5.8M | $17.0M |
| Capital expenditures | -$20.8M | -$23.3M |
| Receipt of deferred key money | $4.7M | $0 |
| Investment in unconsolidated entity | -$1.2M | -$2.3M |
| Return of investment from unconsolidated entity | $30.0K | $1.3M |
| Proceeds from sale of real estate, net | $1.2M | $1.1M |
| Loans funded | -$6.2M | -$10.1M |
| Principal collected on loans | $10.3M | $10.8M |
| Other investing activity | $0 | $82.0K |
| Net cash used in investing activities | -$12.0M | -$22.3M |
| Payment of revolving credit facilities, mortgages payable, term notes and principal on SBA 7(a) loan-backed notes | -$35.0M | -$171.8M |
| Proceeds from revolving credit facilities, term notes and mortgages | $55.5M | $209.7M |
| Payment of principal on secured borrowings | -$52.0K | -$1.6M |
| Payment of deferred preferred stock offering costs | $0 | -$1.6M |
| Payment of deferred costs | -$2.6M | -$4.5M |
| Payment of common dividends | $0 | -$5.8M |
| Net proceeds from issuance of Preferred Stock | -$165.0K | $40.4M |
| Payment of preferred stock dividends | -$22.0M | -$25.6M |
| Redemption of Preferred Stock | $0 | -$25.4M |
| Noncontrolling interests distributions | -$295.0K | -$43.0K |
| Noncontrolling interests contributions | $8.0K | $0 |
| Net cash (used in) provided by financing activities | -$4.6M | $13.9M |
| Decrease in cash balances included in assets held for sale | -$4.4M | $0 |
| NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | -$15.2M | $8.6M |
| Cash paid during the period for interest | $36.4M | $34.9M |
| Federal income taxes paid | $384.0K | $845.0K |
| Accrued capital expenditures, tenant improvements and real estate developments | $4.7M | $7.6M |
| Other amounts due from Unconsolidated Joint Venture partners included in other assets | $396.0K | $396.0K |
| Accrued deferred debt origination costs | $362.0K | $425.0K |
| Accrual of dividends payable to preferred stockholders | $5.0M | $6.0M |
| Preferred stock offering costs offset against redeemable preferred stock | $0 | $1.4M |
| Reclassification of Series A Preferred Stock from temporary equity to permanent equity | $20.8M | $0 |
| Write-off of preferred stock deferred offering costs | $0 | $5.0M |
| Redeemable preferred stock deemed dividends | $0 | $755.0K |
| Accrued Redeemable Preferred Stock fees | $203.0K | $186.0K |
Compare CIM Commercial Trust Corporation with another company
Former names
Timeline
Recent filings
- Sep 10, 20268-K
- Sep 4, 20268-K
- Aug 14, 20268-K
- Aug 14, 202610-Q
- Aug 13, 20264
- Aug 13, 20264
- Aug 13, 20264
- Aug 13, 20264
- Aug 11, 2026S-8
- Aug 10, 2026SCHEDULE 13G/A
- Aug 4, 20268-K
- Jul 15, 20268-K
- Jun 23, 2026DEF 14A
- Jun 23, 20264
- Jun 23, 20264
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- WikidataQ96574679
- SEC EDGARCIK 908311
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12